NCT00006350View on ClinicalTrials.gov

Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2000

Primary Completion Date

November 30, 2001

Study Completion Date

November 30, 2001

Conditions
LeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Interventions
BIOLOGICAL

daclizumab

BIOLOGICAL

therapeutic allogeneic lymphocytes

DRUG

mycophenolate mofetil

DRUG

tacrolimus

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

21201

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT00006350 - Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter